beta2- but not beta1-adrenoceptor activation modulates intracellular oxygen availability

Area of Science:

• Cardiovascular Physiology
• Cellular Oxygen Homeostasis
• Adrenergic Signaling

Background:

• Beta-adrenoceptors (beta-ARs) are vital for cardiovascular function.
• Intracellular oxygen homeostasis is essential for cardiomyocyte survival.
• The effect of beta-AR activation on intracellular oxygen remains largely unknown.

Purpose of the Study:

• To investigate whether beta-adrenoceptor activation modulates intracellular oxygen levels.
• To elucidate the specific beta-AR subtype and signaling pathway involved in oxygen regulation.

Main Methods:

• Utilized mitochondrial and cytosolic target Renilla luciferase assays to measure intracellular oxygen concentration.
• Conducted pharmacological experiments involving beta2-AR activation, G protein inhibition, eNOS blockade, and NO scavenging.

Main Results:

• Beta2-adrenoceptor (beta2-AR) activation was found to specifically regulate intracellular oxygen in cardiomyocytes and COS7 cells.
• The observed effect was dependent on the beta2-AR-Gi-eNOS pathway, as it was blocked by Gi inhibition, eNOS blockade, and NO scavenging.
• Beta2-AR activation led to increased AMP/ATP ratio, AMPK activity, reactive oxygen species (ROS) production, and prolyl hydroxylase activity.

Conclusions:

• The study identifies a novel role for beta2-ARs in regulating intracellular oxygen homeostasis.
• The beta2-AR-Gi-eNOS pathway is implicated in this oxygen modulation.
• Findings suggest that beta2-AR activation influences cellular energy status and enzymatic activities, contributing to signaling specificity and potentially impacting cardiovascular health.